IL1B and B-cell chronic lymphocytic leukemia: As demonstrated with ibrutinib, in NLC acalabrutinib affected signaling cascade during zymosan activation and also the expression of TNF-α and IL-1β The reduction of TNF-α induced by acalabrutinib was also detected in CLL circulating monocytes and HD donors upon fungi stimulation.